MPS II Immunophenotyping
study id #: NCT04976231
condition: MPS II, Mucopolysaccharidosis II, Hunter Syndrome
status: Not yet recruiting
purpose:The purpose of this study is to investigate how participant’s body’s immune system responds to idursulfase, an enzyme replacement therapy (ERT) and find out which types of immune cells are involved in causing untoward responses to the ERT so that the investigators can relate the level of immune response to the treatment.
results: https://clinicaltrials.gov/ct2/show/results/NCT04976231
last updated: February 26, 2022
-
Molecular Analysis and Novel Variation Identification of Chinese Pedigrees With Mucopolysaccharidosis Using Targeted...Mucopolysaccharidosis (MPS) refers to a ...
-
Molecular Analysis of Vietnamese Patients With Mucopolysaccharidosis Type IMucopolysaccharidosis type I (MPS I) is ...
-
What Is Mucopolysaccharidosishttps://www.onempsvoice.com/wp-content/u...
-
Mucopolysaccharidosis Type I Disease Prevalence Among Patients With Idiopathic Short Stature in Saudi Arabia: Protoc...Since the underlying cause of idiopathic...
-
Mucopolysaccharidosis Type 1 (MPS 1)What is Mucopolysaccharidosis Type 1?Muc...
-
Long-Term Evolution of Mucopolysaccharidosis Type I in Twins Treated With Enzyme Replacement Therapy Plus Hematopoie...Mucopolysaccharidoses (MPSs) are a heter...
-
Medical Travel Assistance Program (MTAP)Program provides financial assistance of...